Nordic ListingsIssuer Report
Generic Sweden AB: Quarterly Trading Report 2025 Q3
Generic Sweden AB: Quarterly Trading Report 2025 Q3https://view.news.eu.nasdaq.com/view?id=bd448fb24f6e2645517b2143b56335ed3&lang=en&src=omxlink
Generic Sweden AB: Quarterly Trading Report 2025 Q3
Earlier from Generic Sweden
- GENI: Strong EBIT growth and improved margins in Q2 2025, led by SaaS and secure communication services
- GENI: SaaS-driven margin growth and strong DOCS adoption boost results amid CEO transition
- GENI: Record revenue and profit growth in 2024, fueled by SaaS and public sector wins
- GENI: Record revenue and EBITDA in Q3 2024, driven by SaaS growth and strong demand
- GENI: Q2 2024 saw 25% revenue growth, strong customer gains, and a shift to next-gen messaging
Later from Generic Sweden
- Generic Sweden Q3 Net Sales SEK 45.3 Mln
- Generic Sweden Welcomes Jenny Björk As New CFO
- Generic Sweden Q4 EBIT Falls TO SEK 9.7 Mln
- GENI: Net sales rose 9.1% with robust digitalization growth, but cash flow turned negative on higher receivables
Follow Generic Sweden into a list and get an email when it puts out news.
Follow Generic Sweden